10 Best Diagnostics and Research Stocks to Buy According to Analysts
The diagnostics and research sector holds a crucial position in the healthcare ecosystem, thus attracting investor interest.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 3,914,366 | $896,742,107 | -8% | 4.23% |
| 2. | Coatue Management Philippe Laffont | 2,633,334 | $603,270,486 | +1447% | 1.51% |
| 3. | AQR Capital Management Cliff Asness | 2,599,299 | $595,473,319 | +9% | 0.31% |
| 4. | Castle Hook Partners Josh Donfeld And David Rogers | 2,167,869 | $496,637,110 | +25% | 2.06% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,179,939 | $270,312,226 | +112% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | $562,054.51 | 420,000 | 2022-05-12 | Filing | |
| $28.81 | 159,783 | $4,603,348.23 | 400,989 | 2022-05-12 | Filing | |
| $28.09 | 41,026 | $1,152,358.80 | 241,026 | 2022-05-12 | Filing | |
| $33.49 | 40,695 | $1,362,798.23 | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | $2,799,982.51 | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $205.00 | 1,909 | $391,349.96 | 224,885 | 2026-04-01 | Filing | |
| $203.83 | 1,200 | $244,590.96 | 226,794 | 2026-04-01 | Filing | |
| $203.07 | 3,213 | $652,470.34 | 227,994 | 2026-04-01 | Filing | |
| $202.01 | 1,778 | $359,167.02 | 231,207 | 2026-04-01 | Filing | |
| $200.79 | 300 | $60,236.04 | 232,985 | 2026-04-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 373 | $74,596 | 0.02% | |
| 2. | 12 | $2,400 | 0% | |
| 3. | 9 | $1,800 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Signatera Oncology Test Drives Natera’s (NTRA) Growth
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter can be downloaded here...
Natera, Inc. (NASDAQ:NTRA) Q4 2025 Earnings Call Transcript
Operator: Welcome to Natera's 2025 Fourth Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, February 26, 2026.
Natera, Inc. (NTRA) Announces Results From the SINERGY Trial
Natera, Inc. (NASDAQ:NTRA) is one of the best strong buy healthcare stocks to invest in. On February 24, Natera, Inc.
11 Best Strong Buy Healthcare Stocks to Invest In
On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the stock market and the recent price action in stocks.
Natera, Inc. (NTRA) Reports Preliminary Q4 Revenue
Natera, Inc. (NASDAQ:NTRA) announced preliminary fourth-quarter 2025 revenue of $660 million, exceeding the average forecast of $577.62 million, as reported by TheFly on January 12, 2026.
Growth Stock Portfolio: 12 Stock Picks By Cathie Wood
After a severe 2022 decline, Cathie Wood's flagship innovation fund witnessed a dramatic comeback through 2025, climbing 87.1% in the year ending in September 2025 and tripling over three years, according...
Lack of Natera (NTRA) Exposure Weighs on Voya MidCap Opportunities Fund Performance
Voya Investment Management’s Voya MidCap Opportunities Fund released its Q4 2025 investor letter, titled “Seeking a More Favorable Risk/Return Trade-off”, outlining a quarter marked by solid market...
Natera (NTRA) Surged as Results Beat Expectations
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study
Natera, Inc. (NASDAQ:NTRA) is one of the High Growth Large Cap Stocks to Buy Right Now.
Hedge Fund Resource Center